Lymphoma, Large B-Cell, Diffuse
Showing 9976 - 10000 of >10,000
Risk HDS and HCT in Patients With Haemoblasts.
Recruiting
- Cardiotoxicity
- electrocardiography, echocardiography with the determination of global longitudinal strain, cardiopulmonary exercise test, and diagnostic of endothelial function by Angioscan
-
Moscow, Russian FederationSechenov University
Aug 18, 2022
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Detroit,
Active, not recruiting
- Castration Levels of Testosterone
- +4 more
-
Detroit, Michigan
- +1 more
Aug 30, 2022
Obstructive Sleep Apnea Trial in San Diego, Saint Louis (Mask A (Oran Park Mask) then Mask B (Evora Mask), Mask B (Evora Mask)
Enrolling by invitation
- Obstructive Sleep Apnea
- Mask A (Oran Park Mask) then Mask B (Evora Mask)
- Mask B (Evora Mask) then Mask A (Oran Park Mask)
-
San Diego, California
- +1 more
Oct 6, 2023
Vitamin D Receptor, Interleukin-1A and Interleukin-1B Gene
Completed
- Periodontitis
- Polymorphism, Restriction Fragment Length
-
İstanbul, Maltepe, Turkey
- +1 more
Nov 30, 2021
Glioblastoma Trial in Beijing (B7-H3-targeting CAR-T cells)
Recruiting
- Glioblastoma
- B7-H3-targeting CAR-T cells
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital
Feb 11, 2022
Rheumatoid Arthritis Trial in France (Xrays, Ultrasound (B mode ), Ultrasound (D mode))
Active, not recruiting
- Rheumatoid Arthritis
- Xrays
- +2 more
-
Angers, France
- +9 more
May 7, 2022
Frailty, Childhood Cancer Trial in Memphis (Dasatinib plus Quercetin, Fisetin)
Recruiting
- Frailty
- Childhood Cancer
- Dasatinib plus Quercetin
- Fisetin
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jun 8, 2022
FGFR1 Gene Amplification, FGFR1 Gene Mutation, FGFR1 Gene Translocation Trial in United States (Pemigatinib, Quality-of-Life
Active, not recruiting
- FGFR1 Gene Amplification
- +18 more
- Pemigatinib
- Quality-of-Life Assessment
-
Scottsdale, Arizona
- +5 more
Oct 18, 2022
Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC
Completed
- Small Cell Lung Cancer
- atezolizumab
-
Chalon-sur-Saône, France
- +1 more
Jan 5, 2023
Melanoma, Merkel Cell Carcinoma, Other Solid Tumors Trial in Middletown, Harrison, New York (TALIMOGENE LAHERPAREPVEC (TVEC),
Active, not recruiting
- Melanoma
- +2 more
- TALIMOGENE LAHERPAREPVEC (TVEC)
- Hypofractionated Radiotherapy
-
Middletown, New Jersey
- +2 more
Jul 13, 2022
Cognitive Aftereffects of Neurotoxicity in Children and Young
Not yet recruiting
- Lymphoma
- Leukemia
-
Los Angeles, California
- +2 more
Feb 2, 2023
Advanced Primary Liver Cancer Trial (IBR900 combined with Lenvatinib, IBR900 combined with Bevacizumab)
Not yet recruiting
- Advanced Primary Liver Cancer
- IBR900 combined with Lenvatinib
- IBR900 combined with Bevacizumab
- (no location specified)
Jun 6, 2022
Squamous Cell Carcinoma, Skin Cancer, Keratoacanthoma Trial in Scottsdale, Tucson (Injection of TVEC into target lesions - week
Recruiting
- Squamous Cell Carcinoma
- +5 more
- Injection of TVEC into target lesions - week 1-2
- +3 more
-
Scottsdale, Arizona
- +1 more
Apr 6, 2022
Ophthalmic Trial in Mansoura (measuring depth of anesthesia and its relation to the globe)
Enrolling by invitation
- Ophthalmic
- measuring depth of anesthesia and its relation to the globe
-
Mansoura, EgyptMansoura university
Mar 1, 2022
Immune Tolerance Trial in Palo Alto (Combined Deceased Donor Kidney and Hematopoietic Cell Transplants)
Enrolling by invitation
- Immune Tolerance
- Combined Deceased Donor Kidney and Hematopoietic Cell Transplants
-
Palo Alto, CaliforniaStanford University
May 6, 2022
Thrombotic Microangiopathy Trial in Worldwide (Ravulizumab, Placebo, Best supportive care)
Recruiting
- Thrombotic Microangiopathy
- Ravulizumab
- +2 more
-
Tampa, Florida
- +90 more
Jan 26, 2023
Short- and Long-term Health Effects of Air Pollution in Eastern
Active, not recruiting
- Acute Coronary Syndrome
- +5 more
- Impact of air pollution
-
Białystok, Podlaskie, PolandDepartment of Invasive Cardiology, Medical University of Bialyst
Jan 19, 2022
Hepatocellular Carcinoma Non-resectable, Metastatic Colorectal Cancer, Liver Cancer Trial in Grafton (Eye90 Microspheres)
Recruiting
- Hepatocellular Carcinoma Non-resectable
- +2 more
- Eye90 Microspheres
-
Grafton, New ZealandAuckland District Health Board
Jan 30, 2023
Cervical Carcinoma Trial in Worldwide (LN-145, LN-145 + pembrolizumab)
Recruiting
- Cervical Carcinoma
- LN-145
- LN-145 + pembrolizumab
-
Phoenix, Arizona
- +39 more
Aug 16, 2022
Head and Neck Tumors Trial in Worldwide (biological, drug, radiation)
Active, not recruiting
- Head and Neck Neoplasms
- Pembrolizumab
- +4 more
-
Los Angeles, California
- +150 more
Dec 7, 2022
ADHD Trial (Brief assessment protocol, Comprehensive assessment protocol)
Not yet recruiting
- Attention Deficit Hyperactivity Disorder
- Brief assessment protocol
- Comprehensive assessment protocol
- (no location specified)
Oct 18, 2022
Adolescent Idiopathic Scoliosis, Neuromuscular Scoliosis, Perioperative/Postoperative Complications Trial in New York (Oral
Not yet recruiting
- Adolescent Idiopathic Scoliosis
- +6 more
- Oral ferrous sulfate
- Oral placebo tablet
-
New York, New YorkColumbia University Medical Center
Sep 12, 2023